Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BG2109
DRUG
2 trials
Sponsors
Bio Genuine (Shanghai) Biotech Co., Ltd.
Conditions
Assisted Reproductive Technology
Controlled Ovarian Hyperstimulation
Heavy Menstrual Bleeding
Uterine Fibroids
Phase 2
Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures
NCT05738382
Bio Genuine (Shanghai) Biotech Co., Ltd.
Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation
Start: 2023-08-31
End: 2024-12-31
Target: 240
Updated: 2023-07-27
Phase 3
Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
NCT05620355
Bio Genuine (Shanghai) Biotech Co., Ltd.
Heavy Menstrual Bleeding, Uterine Fibroids
Start: 2022-12-16
End: 2025-03-31
Target: 312
Updated: 2023-03-21